Agios Pharmaceuticals | Betriebsergebnis



Operating Profit Veränderung Datum
AbbVie USD 3.73B 5.22B 2025-03
Agios Pharmaceuticals USD -125037000 1.11B 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 2.31B 182M 2024-12
Arrowhead Research USD -161412000 791K 2024-12
Astellas Pharma JPY 63.52B 179.71B 2025-03
AstraZeneca USD 3.67B 1.64B 2025-03
Bayer EUR 3.53B 7.35B 2024-12
Biogen USD 441.4M 24.4M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Daiichi Sankyo JPY 83.61B 22.2B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Exelixis USD 163.21M 27.13M 2025-01
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Incyte USD 205.17M 96.34M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
Merck USD 5.87B 1.57B 2025-03
Moderna USD -1050000000 196M 2025-03
Novartis USD 2.28B 1.34B 2024-12
Novartis USD 3.4B 193M 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



Agios Pharmaceuticals Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.